➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKesson
Mallinckrodt
Boehringer Ingelheim
Express Scripts
Merck
Colorcon

Last Updated: August 15, 2020

DrugPatentWatch Database Preview

POTASSIUM CITRATE Drug Profile

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Which patents cover Potassium Citrate, and when can generic versions of Potassium Citrate launch?

Potassium Citrate is a drug marketed by Ut Sw Medctr, Ani Pharms Inc, Bionpharma Inc, Rising, Strides Pharma, Teva Pharms Usa Inc, and Zydus Pharms. and is included in seven NDAs.

The generic ingredient in POTASSIUM CITRATE is potassium citrate. There are two hundred and forty drug master file entries for this compound. Eleven suppliers are listed for this compound. Additional details are available on the potassium citrate profile page.

US ANDA Litigation and Generic Entry Outlook for Potassium Citrate

A generic version of POTASSIUM CITRATE was approved as potassium citrate by RISING on June 9th, 2006.

  Start Trial

Drug patent expirations by year for POTASSIUM CITRATE
Drug Prices for POTASSIUM CITRATE

See drug prices for POTASSIUM CITRATE

Recent Clinical Trials for POTASSIUM CITRATE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
National Institute of Dental and Craniofacial Research (NIDCR)Phase 2
Sihuan Pharmaceutical Holdings Group Ltd.Phase 1
Ai PengN/A

See all POTASSIUM CITRATE clinical trials

Pharmacology for POTASSIUM CITRATE
Medical Subject Heading (MeSH) Categories for POTASSIUM CITRATE

US Patents and Regulatory Information for POTASSIUM CITRATE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ut Sw Medctr POTASSIUM CITRATE potassium citrate FOR SOLUTION;ORAL 019647-002 Oct 13, 1988 DISCN Yes No   Start Trial   Start Trial   Start Trial
Rising POTASSIUM CITRATE potassium citrate TABLET, EXTENDED RELEASE;ORAL 077440-001 Jun 9, 2006 AB RX No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc POTASSIUM CITRATE potassium citrate TABLET, EXTENDED RELEASE;ORAL 212779-002 Jan 14, 2020 AB RX No No   Start Trial   Start Trial   Start Trial
Teva Pharms Usa Inc POTASSIUM CITRATE potassium citrate TABLET, EXTENDED RELEASE;ORAL 209758-001 Mar 5, 2018 AB RX No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Johnson and Johnson
Baxter
Express Scripts
Colorcon
Harvard Business School

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.